The millennial-focused digital health company Hims & Hers (HIMS) has donated $1 million to President-elect Donald Trump’s ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Hims offers convenient and affordable access to treatments and products tailored for men's health needs. But how much does it ...

Top hair loss treatment providers, like Hims, use proprietary blends of Rx ... Consult a doctor as some treatment types suited for men may not be suitable for women and vice versa.

When it comes to the efficacy of a hair loss treatment, there’s nothing more telling than a before and after photo.

Hims & Hers (NYSE: HIMS) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the ...

Fintel reports that on January 10, 2025, Citigroup downgraded their outlook for Hims & Hers Health (NYSE:HIMS) from Neutral ...

Hims & Hers Health (HIMS) stock gained after Citi upgraded the company, while agilon health (AGL) stock slipped after its downgrade. Read more here.

Hims & Hers capitalizes on telehealth growth in hair, mental, sexual health, and weight loss. Yet, limited product differentiation, reliance on branding, and FDA risks weaken its long-term moat ...

Hims & Hers Health has seen its stock drop 21% over the past month. The pullback is driven by regulatory updates from the FDA regarding tirzepatide injection shortages. Get 5 New Stock ...

In recent trading, shares of Hims & Hers Health Inc (Symbol: HIMS) have crossed above the average analyst 12-month target price of $25.36, changing hands for $26.63/share. When a stock reaches the ...